Eli Lilly warns EU will miss out on key drugs under new patent rules

Eli Lilly warns EU will miss out on key drugs under new patent rules

David Ricks says draft plan to cut market exclusivity protection could make pursuing some treatments unviable

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner